Home / Non‐Biological Complex Drugs

Non‐Biological Complex Drugs


FDA approves 40 mg follow-on version of glatiramer acetate posted 09/03/2018

Sandoz, the generics division of Novartis, announced on 13 February 2018 the approval of its 40 mg follow-on version of...


Biosimilars and follow-on NBCDs for MS in Europe, the US and Canada posted 19/01/2018

The advent of biological medicines has significantly transformed the landscapes of many disease spaces and improved the lives...


US guidelines for follow-on NBCDs posted 01/06/2018

Last update: 1 June 2018The regulatory body for approval of medicines in the US is the Food and Drug Administration (FDA).

Polices & Legislation

FDA to set up abbreviated pathway for complex products posted 21/10/2016

As part of the Generic Drug User Fee Amendments (GDUFA II) reauthorization recently agreed with industry [1], the US Food and...


Equivalence of complex drug products posted 21/04/2017

Complex drug products and their generic (or follow-on) versions was the subject discussed at the New York Academy of Sciences...

Generics News Research General


Biosimilars News Research General